Ziegler Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$3.43M Sell
124,193
-16,722
-12% -$464K 0.13% 182
2023
Q4
$4.07M Buy
140,915
+12,572
+10% +$380K 0.19% 127
2023
Q3
$4.26M Buy
128,343
+5,334
+4% +$189K 0.17% 176
2023
Q2
$4.51M Sell
123,009
-32,897
-21% -$1.28M 0.17% 176
2023
Q1
$6.37M Buy
155,906
+33,505
+27% +$1.45M 0.25% 150
2022
Q4
$6.23M Sell
122,401
-857
-0.7% -$41.1K 0.26% 138
2022
Q3
$5.39M Sell
123,258
-3,332
-3% -$162K 0.24% 149
2022
Q2
$6.64M Buy
126,590
+5,389
+4% +$275K 0.27% 135
2022
Q1
$6.23M Sell
121,201
-114,591
-49% -$5.95M 0.26% 141
2021
Q4
$13.8M Sell
235,792
-16,848
-7% -$835K 0.5% 72
2021
Q3
$10.8M Sell
252,640
-37,352
-13% -$1.65M 0.39% 99
2021
Q2
$11.4M Sell
289,992
-93,858
-24% -$3.65M 0.38% 95
2021
Q1
$13.9M Sell
383,850
-207,262
-35% -$7.36M 0.44% 76
2020
Q4
$21.8M Sell
591,112
-42,877
-7% -$1.57M 0.72% 24
2020
Q3
$22.1M Sell
633,989
-36,510
-5% -$1.28M 0.85% 17
2020
Q2
$20.8M Sell
670,499
-163,199
-20% -$5.54M 0.66% 29
2020
Q1
$25.8M Buy
+833,698
New +$28.4M 0.69% 29
2013
Q3
$20.6M Buy
757,134
+230,093
+44% +$6.26M 1.8% 4
2013
Q2
$14M Buy
+527,041
New +$14.6M 1.5% 6

Other funds holding PFE

Ziegler Capital Management's PFE Position: Q1 2024 in Review

Ziegler Capital Management reduced its Pfizer (PFE) stake by 12% in Q1 2024, selling an estimated $464K and leaving 124,193 shares worth $3.43M. The position accounts for 0.13% of the portfolio, ranked #182.

Ziegler Capital Management first reported a position in PFE in Q2 2013 and has held it in 19 quarters since. The position peaked at $25.8M in Q1 2020. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Ziegler Capital Management held 124,193 shares of Pfizer worth $3.43M as of Q1 2024.
  • Ziegler Capital Management sold 16,722 Pfizer shares in Q1 2024, an estimated $464K.
  • Pfizer made up 0.13% of Ziegler Capital Management's portfolio in Q1 2024, its #182 holding.
  • Ziegler Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 19 quarters since.
  • Ziegler Capital Management's Pfizer position peaked at $25.8M in Q1 2020.
  • 2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.